CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Juno Therapeutics | Stock-Other | 32.48% | — | — | |
| 2 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 22.51% | — | — | |
| 3 | EGLTEUR | Egalet CORP | Stock-Other | 13.39% | — | — | |
| 4 | FGENEUR | Fibrogen INC | Stock-Other | 12.14% | — | — | |
| 5 | ✓ | Nabriva Therapeutics AG | Stock-Other | 7.12% | — | — | |
| 6 | ✓ | Essa Pharma INC | Stock-Other | 3.83% | — | +55.56% | |
| 7 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 3.27% | — | — | |
| 8 | EDIT | Editas Medicine INC | Stock-Other | 2.52% | — | — | |
| 9 | PRTOEUR | Proteon Therapeutics INC | Stock-Other | 1.34% | — | — | |
| 10 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 0.83% | — | — | |
| 11 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.57% | — | -6.75% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Juno Therapeutics | +2.4% | — | Unchanged |
| 2 | ✓ | Essa Pharma INC | +1.3% | +55.56% | Add |
| 3 | ✓ | Nabriva Therapeutics AG | +1% | — | Unchanged |
| 4 | PIRSEUR | Pieris Pharmaceuticals INC | +0.1% | — | Unchanged |
| 5 | CBAYUSD | Cymabay Therapeutics INC | 0% | -6.75% | Trim |
| 6 | PRTKEUR | Paratek Pharmaceuticals INC | -0.1% | — | Unchanged |
| 7 | DRNAUSD | Dicerna Pharmaceuticals INC | -0.7% | — | Unchanged |
| 8 | PRTOEUR | Proteon Therapeutics INC | -0.8% | — | Unchanged |
| 9 | FGENEUR | Fibrogen INC | -1.8% | — | Unchanged |
| 10 | EGLTEUR | Egalet CORP | -3.9% | — | Unchanged |
| 11 | EDIT | Editas Medicine INC | — | NEW | New buy |